nyse:gsk
|
https://www.glassdoor.com?employer_id=38907
|
38907
|
May 4th, 2024 12:00AM
|
Open
|
GlaxoSmithKline Pharmaceuticals
|
Open
|
Subsidiary or Business Segment
|
Biotech & Pharmaceuticals
|
|
|
Brentford, United Kingdom
|
|
-0.10
|
-10%
|
-10%
|
-10%
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
|
|
|
|
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
0.00
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Open
|
Emma Walmsley
|
May 4th, 2024 06:46PM
|
May 4th, 2024 06:46PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
male
|
white
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=3477
|
3477
|
May 4th, 2024 12:00AM
|
Open
|
GSK
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Brentford, United Kingdom
|
1830
|
3.90
|
73%
|
62%
|
74%
|
3.80
|
3.90
|
3.60
|
4.10
|
3.90
|
3.40
|
85.00
|
141.00
|
477.00
|
1244
|
1423
|
3370
|
640.00
|
518.00
|
2.522%
|
4.184%
|
14.154%
|
36.914%
|
42.226%
|
85.00
|
|
13317
|
0.68
|
0.19
|
0.14
|
0.69
|
|
0.06
|
0.07
|
0.04
|
0.03
|
0.02
|
Open
|
Emma Walmsley
|
May 4th, 2024 06:46PM
|
May 4th, 2024 06:46PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=39188
|
39188
|
May 4th, 2024 12:00AM
|
Open
|
GlaxoSmithKline Consumer Healthcare
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Brentford, United Kingdom
|
2001
|
-0.10
|
-10%
|
-10%
|
-10%
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
|
|
|
|
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
0.00
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Open
|
Emma Walmsley
|
May 4th, 2024 06:46PM
|
May 4th, 2024 06:46PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
male
|
white
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=976806
|
976806
|
May 4th, 2024 12:00AM
|
Open
|
Tesaro
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Waltham, MA
|
2010
|
3.70
|
96%
|
54%
|
64%
|
4.10
|
3.50
|
3.20
|
-1.00
|
3.30
|
3.40
|
|
|
|
|
|
0.00
|
0.00
|
26.00
|
|
|
|
|
|
|
1360
|
43.00
|
0.90
|
|
0.10
|
0.33
|
|
0.56
|
|
0.11
|
|
|
|
Lonnie Moulder
|
May 4th, 2024 06:46PM
|
May 4th, 2024 06:46PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=39089
|
39089
|
May 4th, 2024 12:00AM
|
Open
|
GlaxoSmithKline Vaccines
|
Open
|
Subsidiary or Business Segment
|
Biotech & Pharmaceuticals
|
|
|
Wavre, Belgium
|
1990
|
-0.10
|
-10%
|
-10%
|
-10%
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
|
|
|
|
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
1360
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Open
|
Emma Walmsley
|
May 4th, 2024 06:46PM
|
May 4th, 2024 06:46PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
male
|
white
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=39086
|
39086
|
May 4th, 2024 12:00AM
|
Open
|
GlaxoSmithKline R & D
|
Open
|
Subsidiary or Business Segment
|
Biotech & Pharmaceuticals
|
|
|
Stevenage, United Kingdom
|
|
-0.10
|
-10%
|
-10%
|
-10%
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
|
|
|
|
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
0.00
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Open
|
Emma Walmsley
|
May 4th, 2024 06:46PM
|
May 4th, 2024 06:46PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
male
|
white
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=3477
|
3477
|
May 3rd, 2024 12:00AM
|
Open
|
GSK
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Brentford, United Kingdom
|
1830
|
3.90
|
73%
|
62%
|
74%
|
3.80
|
3.90
|
3.60
|
4.10
|
3.90
|
3.40
|
85.00
|
141.00
|
477.00
|
1247
|
1433
|
3383
|
640.00
|
518.00
|
2.513%
|
4.168%
|
14.1%
|
36.861%
|
42.359%
|
85.00
|
|
13310
|
0.68
|
0.19
|
0.14
|
0.69
|
|
0.06
|
0.07
|
0.04
|
0.03
|
0.02
|
Open
|
Emma Walmsley
|
May 3rd, 2024 03:10PM
|
May 3rd, 2024 03:10PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
|
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=38907
|
38907
|
May 3rd, 2024 12:00AM
|
Open
|
GlaxoSmithKline Pharmaceuticals
|
Open
|
Subsidiary or Business Segment
|
Biotech & Pharmaceuticals
|
|
|
Brentford, United Kingdom
|
|
-0.10
|
-10%
|
-10%
|
-10%
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
|
|
|
|
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
0.00
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Open
|
Emma Walmsley
|
May 3rd, 2024 03:10PM
|
May 3rd, 2024 03:10PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
male
|
white
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=39086
|
39086
|
May 3rd, 2024 12:00AM
|
Open
|
GlaxoSmithKline R & D
|
Open
|
Subsidiary or Business Segment
|
Biotech & Pharmaceuticals
|
|
|
Stevenage, United Kingdom
|
|
-0.10
|
-10%
|
-10%
|
-10%
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
|
|
|
|
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
0.00
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Open
|
Emma Walmsley
|
May 3rd, 2024 03:10PM
|
May 3rd, 2024 03:10PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
male
|
white
|
nyse:gsk
|
https://www.glassdoor.com?employer_id=39188
|
39188
|
May 3rd, 2024 12:00AM
|
Open
|
GlaxoSmithKline Consumer Healthcare
|
Open
|
Company - Public
|
Biotech & Pharmaceuticals
|
|
|
Brentford, United Kingdom
|
2001
|
-0.10
|
-10%
|
-10%
|
-10%
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
-0.10
|
|
|
|
|
|
0.00
|
0.00
|
0.00
|
|
|
|
|
|
|
0.00
|
0.00
|
|
|
|
|
|
|
|
|
|
|
Open
|
Emma Walmsley
|
May 3rd, 2024 03:10PM
|
May 3rd, 2024 03:10PM
|
GlaxoSmithKline
|
Health Care
|
Pharmaceuticals & Biotechnology
|
male
|
white
|